Blockade of bulky lymphoma-associated CD55 expression by RNA interference overcomes resistance to complement-dependent cytotoxicity with rituximab
スポンサーリンク
概要
- 論文の詳細を見る
- 2006-01-10
著者
-
Shiba T
Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research
-
Hatake Kiyohiko
Department Of Medical Oncology Cancer Institute Hospital Of Japanese Foundation For Cancer Research
-
Mishima Yuko
Cancer Chemotherapy Center Clinical Chemotherapy Japanese Foundation For Cancer Research
-
Matsumoto-mishima Yuko
癌研究会癌化学療法センター 臨床研究部
-
Terui Yasuhito
Department Of Medical Oncology Cancer Institute Hospital Of Japanese Foundation For Cancer Research
-
Terui Yasuhito
Division Of Hemopoiesis Institute Of Hematology Jichi Medical School
-
Terui Yasuhito
Department Of Medical Oncology And Hematology Cancer Institute Hospital
-
Takahashi Shunji
Cancer Inst. Hospital Tokyo Jpn
-
Sato Takaaki
Division Of Surgery Tochigi Cancer Center Hospital
-
Hatake Kiyohiko
Division Of Medical Oncology Cancer Institute Hospital
-
TAKAHASHI Shunji
Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resear
-
ITO Yoshinori
Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resear
-
SUGIMURA Natsuhiko
OLYMPUS Bio-Imaging Laboratory, Japanese Foundation for Cancer Research
-
MISHIMA Yuko
Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resear
-
SAKURAI Takuma
Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resear
-
MISHIMA Yuji
Olympus Bio-Imaging Laboratory, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
SASAOKA Chino
Olympus Bio-Imaging Laboratory, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
KOJIMA Kiyotsugu
Olympus Bio-Imaging Laboratory, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
YOKOYAMA Masahiro
Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resear
-
MIZUNUMA Nobuyuki
Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Resear
-
Morishima Yasuo
Department Of Hematology And Chemotherapy
-
Ito Yoshinori
Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research
-
Shiba Tadayoshi
Department Of Molecular Biology Kitasato University
-
Ito Yoshinori
Department Of Medical Oncology Cancer Institute Hospital Japanese Foundation For Cancer Research
-
Takahashi Shunji
Department Of Oncology And Hematology Cancer Institute Hospital
-
Sasaoka Chino
Olympus Bio-imaging Laboratory Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Sakurai Takuma
Division Of Clinical Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Mizunuma Nobuyuki
Department Of Medical Oncology Cancer Institute Hospital Of Japanese Foundation For Cancer Research
-
Mizunuma Nobuyuki
Department Of Medical Oncology Cancer Institute Hospital
-
Yokoyama Masahiro
Department Of Oncology And Hematology Cancer Institute Hospital
-
Takahashi Shunji
Division Of Clinical Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Hatake Kiyohiko
Olympus Bio-imaging Laboratory The Cancer Chemotherapy Center Of The Jfcr
-
Tsukahara Satomi
Department Of Medical Oncology Cancer Institute Hospital Japanese Foundation For Cancer Research
-
Tsukahara Satomi
Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research
-
Ito Yoshinori
Department Of Medical Oncology Cancer Institute Hospital Of Japanese Foundation For Cancer Research
-
Sugimura Natsuhiko
Olympus Bio-imaging Laboratory Japanese Foundation For Cancer Research
-
Ito Yoshinori
Departments Of Pathology Medical Oncology And Breast Oncology The Cancer Institute Hospital Of The J
-
Ito Yoshinori
Division Of Central Clinical Laboratory Nagoya City University Hospital
-
Kojima Kiyotsugu
Olympus Bio-imaging Laboratory Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Ito Yoshinori
Department Of Breast Oncology The Cancer Institute Hospital Of The Japanese Foundation For Cancer Research
関連論文
- ゲノム情報を生かした個別化医療 (特集 固形癌の最新治療--癌治療への新たな取り組み) -- (治療の新たな取り組み 個別化治療)
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- SF-107-4 大腸sm癌のリンパ節転移と遺伝子群のマイクロアレイによる解析(第107回日本外科学会定期学術集会)
- 大腸の増殖形式(PG・NPG)と遺伝子群のマイクロアレイによる解析,悪性度についての検討
- マイクロアレイによる大腸癌の異時性肝転移の高リスク群の抽出
- SY-1-2-5 肝細胞癌の進展機構解析による新規分子標的の同定(シンポジウム1-2 消化器癌の発生機序から見た治療戦略-肝胆膵癌,第62回日本消化器外科学会定期学術総会)
- SY-6-6 癌遺伝子発現パターンを用いたPaclitaxelの治療効果予知 : 局所進行乳癌に対する術前化療による解析
- 早期大腸癌の発育形態と Ras-signaling Pathway 異常(第105回日本外科学会定期学術集会)
- PS-117-2 散発性大腸癌発癌におけるhMLH1発現低下の意義
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- 発がん・増殖 BRCA遺伝子機能とその機能欠損による乳癌発生機序 (乳癌--基礎と臨床の架け橋)
- 図説 最新のゲノムワイド解析技術 (特集 ゲノム研究最前線--疾患ゲノム研究の現状と展望)
- 癌と骨転移のゲノム学 (特集 骨・破壊と再生のゲノム医学)
- 遺伝性乳癌の分子遺伝学--BRCA1を中心に (癌抑制遺伝子--最新トピックス)
- SNPsと有害事象情報 (特集 分子・細胞標的治療--基礎と臨床) -- (基礎)
- 大腸癌表層部と先進部の発現プロファイル解析
- IS-3-4 乳がん術前化学療法の効果予測システム開発の試み(第108回日本外科会定期学術集会)
- A Japanese patient with Li-Fraumeni syndrome who had nine primary malignancies associated with a germline mutation of the p53 tumor-suppressor gene
- SF-108-2 大腸癌先進部脱分化に関与する遺伝子群の同定と機能ネットワークの構築(第107回日本外科学会定期学術集会)
- O-109 原発性肺癌切除時の開胸時胸腔内洗浄液における微量肺癌細胞の検出と細胞診の比較(肺癌と分子生物学2, 第47回日本肺癌学会総会)
- DP-009-4 包括的遺伝子発現解析による膵癌リンパ節転移予測マーカーの同定(第108回日本外科学会定期学術集会)
- Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- P-7 原発性肺癌切除時の開胸時胸腔内洗浄液におけるCEA-mRNAの検出の意義(一般演題(ポスター) トランスレーショナルリサーチ,第48回日本肺癌学会総会)
- t(11 ; 18)-Bearing Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Responding to Cladribine
- Two Entities of Precursor T-Cell Lymphoblastic Leukemia/Lymphoma Based on Radiologic and Immunophenotypic Findings
- Primary Mediastinal Large B-Cell Lymphoma : A Single-Institution Clinical Study in Japan
- EBV-Positive Burkitt Lymphoma as a Late-Onset Posttransplantion Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation
- Primary Hepatic Low-Grade B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type : A Case Report and Review of the Literature
- Successful Allogeneic Bone Marrow Transplantation in a Case of Adult Precursor B-Lymphoblastic Lymphoma
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- 乳がんのLarge-scale genomic study
- Monosomies 7p and 12p and FLT3 internal tandem duplication : possible markers for diagnosis of T/myeloid biphenotypic acute leukemia and its clonal evolution
- HNPCC患者の放射線治療の安全性に関する検討(第105回日本外科学会定期学術集会)
- Histological Features of Breast Cancer, Highly Sensitive to Chemotherapy
- Identifying haplotype block structure using an ancestor-derived model
- Increased incidence of interstitial pneumonia by CHOP combined with rituximab
- A Case of Acute Promyelocytic Leukemia during Gefitinib Treatment
- Functional MRI : Principles and Applications to the Visual System
- B-cell lymphoma accompanying monoclonal macroglobulinemia with features suggesting marginal zone B-cell lymphoma
- Allelic Loss at 1p34,13q12,17p13.3,and 17q21.1 Correlates With Poor Postoperative Prognosis in Breast Cancer
- Correlation of Allelic Loss with Poor Postoperative Survival in Breast Cancer
- PTEN/MMAC1 Mutations in Hepatocellular Carcinomas: Somatic Inactivation of Both Alleles in Tumors
- Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer : cross-resistance to capecitabine
- Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients
- Does Lapatinib, a Small-Molecule Tyrosine Kinase Inhibitor, Constitute a Breakthrough in the Treatment of Breast Cancer?
- Efficacy and Safety of Combined Trastuzumab and Paclitaxel Therapy as a Second-Line Treatment in Women with Metastatic Breast Cancer : A Single Institutional Experience
- High Prevalence of HER-2/neu and p53 Overexpression in Inflammatory Breast Cancer
- Severe Infusion Reaction Induced by Trastuzumab : A Case Report
- Dose-finding phase I study of simultaneous weekly infusion with doxorubicin and docetaxel in patients with advanced breast cancer
- Pilot study of continuous low-dose 5-fluorouracil and cisplatin (FP regimen) for the treatment of metastatic breast cancer
- Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray
- Amplification, up-regulation and over-expression of DVL-1, the human counterpart of the Drosophila disheveled gene, in primary breast cancers
- Tocilizumab is effective for pulmonary hypertension associated with multicentric Castleman's disease
- High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families
- Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer
- Next Generation Molecular Targeted Agents for Breast Cancer : Focus on EGFR and VEGFR Pathways
- 癌抑制遺伝子BRCA1/2の機能およびPARP阻害剤によるBRCA変異陽性乳癌の治療 (特集 癌治療・発癌・老化の鍵を握るDNA修復経路)
- Chemotherapy for Small-Bowel Adenocarcinoma at a Single Institution
- Autophagy and autophagic cell death are next targets for elimination of the resistance to tyrosine kinase inhibitors
- Modified irinotecan plus bolus 5-fluorouracil/L-leucovorin for metastatic colorectal cancer at a single institution in Japan
- Continuous treatment of bestatin induces anti-angiogenic property in endothelial cells
- Differential Regulation of Eotaxin-1/CCL11 and Eotaxin-3/CCL26 Production by the TNF-α and IL-4 Stimulated Human Lung Fibroblast(Pharmacology)
- Blockade of bulky lymphoma-associated CD55 expression by RNA interference overcomes resistance to complement-dependent cytotoxicity with rituximab
- Gene Therapy for Breast Cancer.-Review of Clinical Gene Therapy Trials for Breast Cancer and MDR1 Gene Therapy Trial in Cancer Institute Hospital
- Familial breast and ovarian cancers
- Sentinel Lymph Node Biopsy Using Tin Colloid RI and Blue Dye Method
- Tolerability and Safety of Classic Cyclophosphamide, Methotrexate, and Fluorouracil Treatment in Japanese Patients with Early Breast Cancer
- 遺伝子診断の展望 (乳癌--基礎・臨床研究のアップデート) -- (臨床研究 診断 遺伝子診断)
- マイクロアレイ技術と薬剤感受性評価 (あゆみ 抗癌剤感受性試験の進歩)
- Functional pathway characterized by gene expression analysis of supraclavicular lymph node metastasis-positive breast cancer
- Improved detection of axillary hot nodes in lymphoscintigraphy in breast cancer located in the upper lateral quadrant with additional projection imaging
- 単一遺伝子病とゲノム--テーマ2 遺伝性悪性腫瘍(1)家族性乳癌
- A Clinicopathologic Study of Breast Cancer Patients during Pregnancy
- Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
- Molecular markers associated with lymph node metastasis in pancreatic ductal adenocarcinoma by genome-wide expression profiling
- Genotyping of Single Nucleotide Polymorphisms Based on a Mathematical Model for Two-Dimensional Data
- Functional in vivo optical imaging of tumor angiogenesis, growth, and metastasis prevented by administration of anti-human VEGF antibody in xenograft model of human fibrosarcoma HT1080 cells
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Possible use of combination chemotherapy with mitomycin C and methotrexate for metastatic breast cancer pretreated with anthracycline and taxanes
- Complete Resection After Imatinib Treatment of a Gastrointestinal Stromal Tumor of the Ileum with Peritoneal Metastases : Report of a Case
- Estrone and 17β-Estradiol Reverse Breast Cancer Resistance Protein-mediated Multidrug Resistance
- Identification and Characterization of a Deletion Mutant of DNA Topoisomerase I mRNA in a Camptothecin-resistant Subline of Human Colon Carcinoma
- Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
- Dlk-1, a cell surface antigen on foetal hepatic stem/progenitor cells, is expressed in hepatocellular, colon, pancreas and breast carcinomas at a high frequency
- Anal Canal Carcinoma with Pagetoid Spread : Report of a Case
- Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells
- Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancer
- Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer
- Predictors of the Efficacy of FOLFIRI plus Bevacizumab as Second-Line Treatment in Metastatic Colorectal Cancer Patients
- Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients
- Incidence of chemotherapy-induced amenorrhea in premenopausal patients with breast cancer following adjuvant anthracycline and taxane
- Phase I study of dasatinib (BMS-354825) in Japanese patients with solid tumors